MDNAF

Medicenna Therapeutics Corp.

MDNAF·58490H107·US·Common Stock·Healthcare - Biotechnology

MDNAF (Medicenna Therapeutics Corp.) is held by 1 institutional investors as of Q4 2023. Largest holders: Rathbones Group PLC ($33,812). Net institutional sentiment: Bearish.

1
Holders
Avg rating(4 Elite)
$33,812
Total Value
0% (11)
Fund Consensus
0 buying - 10 selling

No verdict yet — fewer than 2 funds hold MDNAF.

13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
105,663$33,8120.0%-86.97%
0
Exited
0(-100.0%)$223,1630.0%-61.73%
0
Exited
0(-100.0%)$3,0320.0%-40.38%
0
Exited
0(-100.0%)$6,4880.0%-88.06%
0
Exited
0(-100.0%)$25,0000.0%-58.90%
0
Exited
0(-100.0%)$3,0000.0%-40.38%
0
Exited
0(-100.0%)$7,1440.0%+6.90%
0
Exited
0(-100.0%)$2110.0%+6.90%
0
Exited
0(-100.0%)$7,8980.0%+6.90%
0
Exited
0(-100.0%)$158,7870.0%-93.02%
0
Exited
0(-100.0%)$9,7610.0%-90.03%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used